2024 Q1 Form 10-Q Financial Statement

#000174448924000081 Filed on February 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $22.08B $23.55B
YoY Change 16.87%
Cost Of Revenue $14.17B $15.59B
YoY Change -20.51%
Gross Profit $7.911B $7.962B
YoY Change 1369.0%
Gross Profit Margin 35.82% 33.81%
Selling, General & Admin $3.790B $3.783B
YoY Change -20.07%
% of Gross Profit 47.91% 47.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.242B $1.243B
YoY Change -5.62%
% of Gross Profit 15.7% 15.61%
Operating Expenses $3.790B $3.783B
YoY Change -6104.76%
Operating Profit $3.845B $3.876B
YoY Change 540.66%
Interest Expense $501.0M $528.0M
YoY Change -330.57%
% of Operating Profit 13.03% 13.62%
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income $657.0M $2.871B
YoY Change 663.56%
Income Tax $441.0M $720.0M
% Of Pretax Income 67.12% 25.08%
Net Earnings -$20.00M $1.911B
YoY Change 1079.63%
Net Earnings / Revenue -0.09% 8.11%
Basic Earnings Per Share -$0.01 $1.04
Diluted Earnings Per Share -$0.01 $1.04
COMMON SHARES
Basic Shares Outstanding 1.834B shares 1.830B shares
Diluted Shares Outstanding 1.834B shares 1.835B shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.635B $7.192B
YoY Change -38.08%
Cash & Equivalents $6.635B $7.192B
Short-Term Investments
Other Short-Term Assets $2.106B $1.301B
YoY Change -57.88%
Inventory $1.948B $1.954B
Prepaid Expenses
Receivables $12.03B $14.12B
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.64B $25.97B
YoY Change -10.75%
LONG-TERM ASSETS
Property, Plant & Equipment $35.53B $35.32B
YoY Change 5.13%
Goodwill $73.91B $77.07B
YoY Change -1.07%
Intangibles $11.47B $12.64B
YoY Change -14.81%
Long-Term Investments $3.007B $3.084B
YoY Change -4.16%
Other Assets $13.96B $10.97B
YoY Change 19.11%
Total Long-Term Assets $170.5B $171.8B
YoY Change -1.56%
TOTAL ASSETS
Total Short-Term Assets $24.64B $25.97B
Total Long-Term Assets $170.5B $171.8B
Total Assets $195.1B $197.8B
YoY Change -2.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.80B $18.68B
YoY Change -7.6%
Accrued Expenses
YoY Change
Deferred Revenue $6.156B $5.641B
YoY Change 1.99%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.789B $6.087B
YoY Change 98.27%
Total Short-Term Liabilities $32.87B $31.03B
YoY Change 6.74%
LONG-TERM LIABILITIES
Long-Term Debt $39.51B $41.60B
YoY Change -8.16%
Other Long-Term Liabilities $12.10B $12.60B
YoY Change 0.62%
Total Long-Term Liabilities $51.61B $54.20B
YoY Change -6.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.87B $31.03B
Total Long-Term Liabilities $51.61B $54.20B
Total Liabilities $84.49B $85.23B
YoY Change -21.53%
SHAREHOLDERS EQUITY
Retained Earnings $46.65B $47.49B
YoY Change 8.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.916B $907.0M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $99.25B $100.7B
YoY Change
Total Liabilities & Shareholders Equity $195.1B $197.8B
YoY Change -2.88%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$20.00M $1.911B
YoY Change 1079.63%
Depreciation, Depletion And Amortization $1.242B $1.243B
YoY Change -5.62%
Cash From Operating Activities $3.666B $2.185B
YoY Change -13.43%
INVESTING ACTIVITIES
Capital Expenditures $1.259B $1.299B
YoY Change -213.15%
Acquisitions
YoY Change
Other Investing Activities -$48.00M -$53.00M
YoY Change -541.67%
Cash From Investing Activities -$1.307B -$1.246B
YoY Change 9.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $309.0M
YoY Change -69.1%
Cash From Financing Activities -2.818B -$8.006B
YoY Change 222.56%
NET CHANGE
Cash From Operating Activities 3.666B $2.185B
Cash From Investing Activities -1.307B -$1.246B
Cash From Financing Activities -2.818B -$8.006B
Net Change In Cash -459.0M -$6.988B
YoY Change 538.76%
FREE CASH FLOW
Cash From Operating Activities $3.666B $2.185B
Capital Expenditures $1.259B $1.299B
Free Cash Flow $2.407B $886.0M
YoY Change -75.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4600000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4600000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1900000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1800000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1900000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1800000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
19000000 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
19000000 shares
CY2023Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
These facilities allow for borrowings at rates based on the Secured Overnight Financing Rate (SOFR), and at other variable rates for non-U.S. dollar denominated borrowings, plus a fixed spread that varies with the Company’s debt ratings assigned by Moody’s Investors Service and Standard and Poor’s ranging from 0.655% to 1.225%.
CY2023Q4 dis Hedged Instruments Maturity Upper Limit
HedgedInstrumentsMaturityUpperLimit
P4Y
CY2023Q4 us-gaap Revenues
Revenues
23549000000 usd
CY2022Q4 us-gaap Revenues
Revenues
23512000000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3783000000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3827000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1243000000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1306000000 usd
CY2023Q4 us-gaap Costs And Expenses
CostsAndExpenses
20613000000 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
21519000000 usd
CY2023Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
69000000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42000000 usd
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-246000000 usd
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-300000000 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
181000000 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
191000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2871000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1773000000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
720000000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
412000000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
2151000000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
1361000000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240000000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
82000000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1911000000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1279000000 usd
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1835000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1827000000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1832000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1825000000 shares
CY2023Q4 us-gaap Profit Loss
ProfitLoss
2151000000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
1361000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-319000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-542000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
21000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
174000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
227000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-166000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-314000000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1985000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1047000000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240000000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
82000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
44000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
45000000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1701000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
920000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7192000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14182000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
14115000000 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
12330000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1954000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
1963000000 usd
CY2023Q4 dis Licensed Content Costs And Advances
LicensedContentCostsAndAdvances
1409000000 usd
CY2023Q3 dis Licensed Content Costs And Advances
LicensedContentCostsAndAdvances
3002000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1301000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1286000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
25971000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
32763000000 usd
CY2023Q4 dis Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
32725000000 usd
CY2023Q3 dis Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
33591000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
3084000000 usd
CY2023Q3 us-gaap Long Term Investments
LongTermInvestments
3080000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72096000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
70090000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43575000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42610000000 usd
CY2023Q4 dis Parks Resorts And Other Property At Cost Excluding Projects And Land
ParksResortsAndOtherPropertyAtCostExcludingProjectsAndLand
28521000000 usd
CY2023Q3 dis Parks Resorts And Other Property At Cost Excluding Projects And Land
ParksResortsAndOtherPropertyAtCostExcludingProjectsAndLand
27480000000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
5618000000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6285000000 usd
CY2023Q4 us-gaap Land
Land
1182000000 usd
CY2023Q3 us-gaap Land
Land
1176000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35321000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34941000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12639000000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13061000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
77066000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
77067000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10968000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11076000000 usd
CY2023Q4 us-gaap Assets
Assets
197774000000 usd
CY2023Q3 us-gaap Assets
Assets
205579000000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18676000000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
20671000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6087000000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4330000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6270000000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6138000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31033000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31139000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
41603000000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
42101000000 usd
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
7041000000 usd
CY2023Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
7258000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12596000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12069000000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 usd
CY2023Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
9055000000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
57640000000 usd
CY2023Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
57383000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
47490000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
46093000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3502000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3292000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
907000000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
907000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
100721000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99277000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
4780000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
4680000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
105501000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103957000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
197774000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205579000000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
2151000000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
1361000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1243000000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-51000000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-15000000 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
181000000 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
191000000 usd
CY2023Q4 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
153000000 usd
CY2022Q4 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
176000000 usd
CY2023Q4 us-gaap Increase Decrease In Film Costs1
IncreaseDecreaseInFilmCosts1
-2642000000 usd
CY2022Q4 us-gaap Increase Decrease In Film Costs1
IncreaseDecreaseInFilmCosts1
-558000000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
308000000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
270000000 usd
CY2023Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-64000000 usd
CY2022Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-163000000 usd
CY2023Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1554000000 usd
CY2022Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1423000000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8000000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
88000000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30000000 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
443000000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1396000000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2378000000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1104000000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
56000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2185000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-974000000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1299000000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1181000000 usd
CY2023Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-53000000 usd
CY2022Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
111000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1246000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1292000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
1046000000 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
799000000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
67000000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
309000000 usd
CY2022Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000000 usd
CY2023Q4 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2022Q4 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
178000000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
8610000000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
900000000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-133000000 usd
CY2022Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-187000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8006000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1043000000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79000000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6988000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3145000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14235000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11661000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7247000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8516000000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3876000000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3043000000 usd
CY2023Q4 dis Amortizationof Intangible Assets Heldby Equity Investees
AmortizationofIntangibleAssetsHeldbyEquityInvestees
-3000000 usd
CY2022Q4 dis Amortizationof Intangible Assets Heldby Equity Investees
AmortizationofIntangibleAssetsHeldbyEquityInvestees
-3000000 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
181000000 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
191000000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3876000000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3043000000 usd
CY2023Q4 us-gaap Other General Expense
OtherGeneralExpense
308000000 usd
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
280000000 usd
CY2023Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
69000000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42000000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-246000000 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-300000000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
451000000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
579000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2871000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1773000000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
451000000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
579000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
77067000000 usd
CY2023Q4 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-1000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
77066000000 usd
CY2023Q4 us-gaap Revenues
Revenues
23549000000 usd
CY2022Q4 us-gaap Revenues
Revenues
23512000000 usd
CY2023Q4 us-gaap Revenues
Revenues
23549000000 usd
CY2022Q4 us-gaap Revenues
Revenues
23512000000 usd
CY2023Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
300000000 usd
CY2022Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
300000000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14000000000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11810000000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10279000000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1191000000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1212000000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
156000000 usd
CY2023Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
154000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5641000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5568000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
952000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
977000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7192000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14182000000 usd
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
55000000 usd
CY2023Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
53000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7247000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14235000000 usd
CY2023Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
46431000000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1296000000 usd
CY2023Q4 us-gaap Repayments Of Debt
RepaymentsOfDebt
559000000 usd
CY2023Q4 us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
522000000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
47690000000 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
12250000000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
12250000000 usd
CY2023Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
These facilities allow for borrowings at rates based on the Secured Overnight Financing Rate (SOFR), and at other variable rates for non-U.S. dollar denominated borrowings, plus a fixed spread that varies with the Company’s debt ratings assigned by Moody’s Investors Service and Standard and Poor’s ranging from 0.655% to 1.225%.
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1700000000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
528000000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
465000000 usd
CY2023Q4 us-gaap Investment Income Net
InvestmentIncomeNet
182000000 usd
CY2022Q4 us-gaap Investment Income Net
InvestmentIncomeNet
79000000 usd
CY2023Q4 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-100000000 usd
CY2022Q4 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-86000000 usd
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-246000000 usd
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-300000000 usd
CY2023Q4 us-gaap Film Monetized On Its Own Capitalized Cost Released
FilmMonetizedOnItsOwnCapitalizedCostReleased
4911000000 usd
CY2023Q4 us-gaap Film Monetized In Film Group Capitalized Cost Released
FilmMonetizedInFilmGroupCapitalizedCostReleased
13725000000 usd
CY2023Q4 dis Film Capitalized Cost Released
FilmCapitalizedCostReleased
18636000000 usd
CY2023Q3 us-gaap Film Monetized On Its Own Capitalized Cost Released
FilmMonetizedOnItsOwnCapitalizedCostReleased
4968000000 usd
CY2023Q3 us-gaap Film Monetized In Film Group Capitalized Cost Released
FilmMonetizedInFilmGroupCapitalizedCostReleased
13555000000 usd
CY2023Q3 dis Film Capitalized Cost Released
FilmCapitalizedCostReleased
18523000000 usd
CY2023Q4 us-gaap Film Monetized On Its Own Capitalized Cost Completed And Not Released
FilmMonetizedOnItsOwnCapitalizedCostCompletedAndNotReleased
0 usd
CY2023Q4 us-gaap Film Monetized In Film Group Capitalized Cost Completed And Not Released
FilmMonetizedInFilmGroupCapitalizedCostCompletedAndNotReleased
1713000000 usd
CY2023Q4 dis Film Capitalized Cost Completed And Not Released
FilmCapitalizedCostCompletedAndNotReleased
1713000000 usd
CY2023Q3 us-gaap Film Monetized On Its Own Capitalized Cost Completed And Not Released
FilmMonetizedOnItsOwnCapitalizedCostCompletedAndNotReleased
70000000 usd
CY2023Q3 us-gaap Film Monetized In Film Group Capitalized Cost Completed And Not Released
FilmMonetizedInFilmGroupCapitalizedCostCompletedAndNotReleased
1786000000 usd
CY2023Q3 dis Film Capitalized Cost Completed And Not Released
FilmCapitalizedCostCompletedAndNotReleased
1856000000 usd
CY2023Q4 us-gaap Film Monetized On Its Own Capitalized Cost Production
FilmMonetizedOnItsOwnCapitalizedCostProduction
3157000000 usd
CY2023Q4 us-gaap Film Monetized In Film Group Capitalized Cost Production
FilmMonetizedInFilmGroupCapitalizedCostProduction
5394000000 usd
CY2023Q4 dis Film Capitalized Cost Production
FilmCapitalizedCostProduction
8551000000 usd
CY2023Q3 us-gaap Film Monetized On Its Own Capitalized Cost Production
FilmMonetizedOnItsOwnCapitalizedCostProduction
3331000000 usd
CY2023Q3 us-gaap Film Monetized In Film Group Capitalized Cost Production
FilmMonetizedInFilmGroupCapitalizedCostProduction
6120000000 usd
CY2023Q3 dis Film Capitalized Cost Production
FilmCapitalizedCostProduction
9451000000 usd
CY2023Q4 us-gaap Film Monetized On Its Own Capitalized Cost Development And Preproduction
FilmMonetizedOnItsOwnCapitalizedCostDevelopmentAndPreproduction
262000000 usd
CY2023Q4 us-gaap Film Monetized In Film Group Capitalized Cost Development And Preproduction
FilmMonetizedInFilmGroupCapitalizedCostDevelopmentAndPreproduction
132000000 usd
CY2023Q4 dis Film Capitalized Cost Development And Preproduction
FilmCapitalizedCostDevelopmentAndPreproduction
394000000 usd
CY2023Q3 us-gaap Film Monetized On Its Own Capitalized Cost Development And Preproduction
FilmMonetizedOnItsOwnCapitalizedCostDevelopmentAndPreproduction
279000000 usd
CY2023Q3 us-gaap Film Monetized In Film Group Capitalized Cost Development And Preproduction
FilmMonetizedInFilmGroupCapitalizedCostDevelopmentAndPreproduction
133000000 usd
CY2023Q3 dis Film Capitalized Cost Development And Preproduction
FilmCapitalizedCostDevelopmentAndPreproduction
412000000 usd
CY2023Q4 us-gaap Film Monetized On Its Own Capitalized Cost
FilmMonetizedOnItsOwnCapitalizedCost
8330000000 usd
CY2023Q4 us-gaap Film Monetized In Film Group Capitalized Cost
FilmMonetizedInFilmGroupCapitalizedCost
20964000000 usd
CY2023Q4 us-gaap Film Costs
FilmCosts
29294000000 usd
CY2023Q3 us-gaap Film Monetized On Its Own Capitalized Cost
FilmMonetizedOnItsOwnCapitalizedCost
8648000000 usd
CY2023Q3 us-gaap Film Monetized In Film Group Capitalized Cost
FilmMonetizedInFilmGroupCapitalizedCost
21594000000 usd
CY2023Q3 us-gaap Film Costs
FilmCosts
30242000000 usd
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
4840000000 usd
CY2023Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
6351000000 usd
CY2023Q4 dis Produced And Licensed Content Total
ProducedAndLicensedContentTotal
34134000000 usd
CY2023Q3 dis Produced And Licensed Content Total
ProducedAndLicensedContentTotal
36593000000 usd
CY2023Q4 dis Licensed Content Costs And Advances
LicensedContentCostsAndAdvances
1409000000 usd
CY2023Q3 dis Licensed Content Costs And Advances
LicensedContentCostsAndAdvances
3002000000 usd
CY2023Q4 dis Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
32725000000 usd
CY2023Q3 dis Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
33591000000 usd
CY2023Q4 dis Amortization Of Produced Content Costs
AmortizationOfProducedContentCosts
2562000000 usd
CY2022Q4 dis Amortization Of Produced Content Costs
AmortizationOfProducedContentCosts
3317000000 usd
CY2023Q4 dis Amortization Of Licensed Television And Programming Rights
AmortizationOfLicensedTelevisionAndProgrammingRights
4590000000 usd
CY2022Q4 dis Amortization Of Licensed Television And Programming Rights
AmortizationOfLicensedTelevisionAndProgrammingRights
4539000000 usd
CY2023Q4 dis Amortization Of Produced And Licensed Content Costs Total
AmortizationOfProducedAndLicensedContentCostsTotal
7152000000 usd
CY2022Q4 dis Amortization Of Produced And Licensed Content Costs Total
AmortizationOfProducedAndLicensedContentCostsTotal
7856000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2500000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2500000000 usd
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
300000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-221000000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1832000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1825000000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1835000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1827000000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39000000 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26000000 shares
CY2023Q4 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2023-11-30
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
549000000 usd
CY2023Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-12-11
CY2023Q3 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
-3887000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-143000000 usd
CY2023Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
164000000 usd
CY2023Q4 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
-4194000000 usd
CY2022Q4 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
-4980000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-329000000 usd
CY2022Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
175000000 usd
CY2022Q4 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
-5484000000 usd
CY2023Q3 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
595000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
59000000 usd
CY2023Q4 us-gaap Reclassification From Aoci Current Period Tax
ReclassificationFromAociCurrentPeriodTax
-38000000 usd
CY2023Q4 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
692000000 usd
CY2022Q4 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
861000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
108000000 usd
CY2022Q4 us-gaap Reclassification From Aoci Current Period Tax
ReclassificationFromAociCurrentPeriodTax
-37000000 usd
CY2022Q4 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
1006000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3292000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-84000000 usd
CY2023Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
126000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3502000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4119000000 usd
CY2022Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
138000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4478000000 usd
CY2023Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
17000000 usd
CY2022Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19000000 usd
CY2023Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
291000000 usd
CY2022Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
251000000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
308000000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
270000000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
44000000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
36000000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
32.06
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.71
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
93.87
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
91.89
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
12677000000 usd
CY2023Q3 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
12187000000 usd
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-1313000000 usd
CY2023Q3 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-1753000000 usd
CY2023Q4 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
230000000 usd
CY2023Q4 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-264000000 usd
CY2022Q4 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-502000000 usd
CY2023Q4 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
141000000 usd
CY2022Q4 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
222000000 usd
CY2023Q4 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
1500000000 usd
CY2023Q3 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
1600000000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3783000000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3827000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1243000000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1306000000 usd
CY2023Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
69000000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42000000 usd
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-246000000 usd
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-300000000 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
181000000 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
191000000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
720000000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
412000000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240000000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
82000000 usd

Files In Submission

Name View Source Status
dis-20231230_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001744489-24-000081-index-headers.html Edgar Link pending
0001744489-24-000081-index.html Edgar Link pending
0001744489-24-000081.txt Edgar Link pending
0001744489-24-000081-xbrl.zip Edgar Link pending
dis-20231230.htm Edgar Link pending
dis-20231230.xsd Edgar Link pending
dis-20231230_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fy2024_q1x10qxex101.htm Edgar Link pending
fy2024_q1x10qxex103.htm Edgar Link pending
fy2024_q1x10qxex104.htm Edgar Link pending
fy2024_q1x10qxex106.htm Edgar Link pending
fy2024_q1x10qxex107.htm Edgar Link pending
fy2024_q1x10qxex108.htm Edgar Link pending
fy2024_q1x10qxex109.htm Edgar Link pending
fy2024_q1x10qxex22.htm Edgar Link pending
fy2024_q1x10qxex31a.htm Edgar Link pending
fy2024_q1x10qxex31b.htm Edgar Link pending
fy2024_q1x10qxex32a.htm Edgar Link pending
fy2024_q1x10qxex32b.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
dis-20231230_cal.xml Edgar Link unprocessable
dis-20231230_def.xml Edgar Link unprocessable
dis-20231230_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dis-20231230_lab.xml Edgar Link unprocessable